Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Display:
?
Drug:  sonidegib
Find trials that include:  Any drugs shown
Results 1-9 of 9 for your search:
Start Over
Erismodegib and Paclitaxel in Treating Patients with Recurrent Ovarian Cancer
Status: Active
Phase: Phase II, Phase I
Type: Treatment
Age: 19 and over
Trial IDs: UAB 1357, NCI-2015-01335, F140214007, NCT02195973
Sonidegib and Lenalidomide after Stem Cell Transplant in Treating Patients with Multiple Myeloma
Status: Active
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: MC128B, NCI-2014-00170, NCT02086552
Azacitidine and Sonidegib or Decitabine in Treating Patients with Myeloid Malignancies
Status: Active
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: MC1389, NCI-2014-00866, Mod13-009003-08, NCT02129101
Sonidegib and Everolimus in Treating Patients with Locally Advanced or Metastatic Gastroesophageal Cancer That Cannot Be Removed by Surgery
Status: Active
Phase: Phase I
Type: Treatment
Age: 18 and over
Trial IDs: 2013-0838, NCI-2014-01455, NCT02138929
Sonidegib in Treating Patients with Advanced or Metastatic Liver Cancer That Cannot Be Removed by Surgery or Child-Pugh A/B7 Cirrhosis
Status: Active
Phase: Phase I
Type: Treatment
Age: 18 and over
Trial IDs: CLDE225XUS12T, NCI-2014-01762, 131053, HRPP #131053, NCT02151864
Sonidegib in Treating Patients with Refractory Chronic Graft-versus-Host Disease after Donor Stem Cell Transplant
Status: Active
Phase: Phase I
Type: Biomarker/Laboratory analysis, Supportive care
Age: 18 and over
Trial IDs: 13-598, NCI-2015-00622, LDE225XUS16T, NCT02086513
Erismodegib in Treating Patients with High-Risk Localized Prostate Cancer
Status: Active
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: J1402, NCI-2014-02144, LDE225XUS13T, NA_00091602, NCT02111187
Sonidegib and Buparlisib in Treating Patients with Advanced or Metastatic Basal Cell Cancer
Status: Active
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: SKIN0020, NCI-2014-02200, 5136, NCT02303041
Start Over